Galectin Therapeutics Inc. Share Price
GALTGalectin Therapeutics Inc. Stock Performance
Open $4.31 | Prev. Close $4.18 | Circuit Range N/A |
Day Range $3.92 - $4.31 | Year Range $2.02 - $7.13 | Volume 23,047 |
Average Traded $3.99 |
Galectin Therapeutics Inc. Share Price Chart
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in Phase 2b/3 clinical trial to prevent esophageal varices in patient with non-alcoholic steatohepatitis cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. Galectin Therapeutics Inc. has a collaborative joint venture co-owned by SBH Sciences, Inc. with Galectin Sciences, LLC for the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Galectin Therapeutics Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $4.21 | $4.17 | -1.30% |
16-Jul-26 | $4.63 | $4.22 | -11.24% |
15-Jul-26 | $5.20 | $4.76 | -10.69% |
14-Jul-26 | $4.99 | $5.33 | +16.12% |
13-Jul-26 | $4.05 | $4.59 | +13.33% |
10-Jul-26 | $4.36 | $4.05 | -6.68% |
09-Jul-26 | $4.51 | $4.34 | -3.98% |
FAQs on Galectin Therapeutics Inc. Share Price
Can I buy Galectin Therapeutics Inc. shares in India?
What is the share price of Galectin Therapeutics Inc.?
What is the 5 year returns of Galectin Therapeutics Inc.?
What are the high & low stock price of Galectin Therapeutics Inc. today?
What is the 52-week high and low of Galectin Therapeutics Inc. stock?